Mar 8, 2023 · Sam Altman, the CEO of ChatGPT-maker OpenAI, takes a diabetes drug called metformin as part of his efforts to live longer, the MIT Technology Review reported. Metformin is a decades-old drug...

May 24, 2023 · Taking metformin is an important part of Altman’s anti-aging regime, according to MIT Technology Review. Good choice. Metformin is an effective, safe, and proven drug used to treat type 2 diabetes.

Mar 8, 2023 · For his part, Altman says his personal anti-aging regime consists of “trying to eat healthy, exercise, sleep enough” and taking metformin, a diabetes drug that has also become popular in ...

May 18, 2023 · Tech execs are turning to prescription pills like metformin and rapamycin to slow aging. These drugs tame "zombie cells" which can contribute to age-related diseases.

Mar 10, 2023 · OpenAI CEO Sam Altman takes the diabetes drug metformin to slow down aging. His anti-aging regimen also includes healthy eating, exercising, and getting enough sleep. He’s secretly invested in Retro Biosciences, a startup whose mission is to “add 10 years to healthy human lifespan.”

Apr 8, 2023 · He points to existing medications — such as the diabetes tablet metformin - that could be retooled as anti-aging treatments in the 'very, very near term'. Sam Altman (left), founder of...

Sam Altman, the CEO of ChatGPT-maker OpenAI, takes a diabetes drug called metformin as part of his efforts to live longer, the MIT Technology Review reported.

He also said quarterly blood testing had helped him supplement his diet with a range of vitamins, and he has been reported to take the diabetes drug metformin to slow down aging. Altman said...

Aug 7, 2024 · Particularly when demi-god techies like Sam Altman publicly admit to using it for its off-label ‘benefit’. So, what are you supposed to do? Let’s test-drive the miracle drug idea on the roads...

Jan 6, 2024 · Metformin, an extract of the French lilac, has been around for centuries to treat various illnesses. Eventually, it was proved to be effective in lowering glucose levels, which led to its 1994...